Cytokines and etiopathogenesis of pervasive developmental disorders

Medical Hypotheses

Volumn 56, Issue 3, 2001, Pages 321-324

  Malek Ahmadi, P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR;

ARTICLE; AUTISM; CYTOKINE PRODUCTION; DEVELOPMENTAL DISORDER; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; NERVE CELL DIFFERENTIATION; NEUROTOXICITY; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0035028913     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1278     Document Type: Article

References (34)

1. Treffers PDA. Autism and the immune system
2. Neuropathology of infantile autism
3. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal cholinergic neurons from postnatal rats
4. Generation of sensory neurons is stimulated by leukemia inhibitory factor
5. Cachectin/tumour necrosis factor
6. Developmental changes in progenitor cell responsiveness to cytokines
7. Hematolymphopoietic and inflammatory cytokines in neural development
8. Changes in soluble interleukin-2 production, interleukin-2 receptor, T8 antigen, interleukin-1 in the serum of autistic children
9. Lymphocyte function in autism and Rett syndrome
10. Interferonemia and autism
11. Lymphocyte subsets and interleukin-2 receptors in autistic children
12. Plasma increase of interleukin-12 and interferon-γ. Pathological significance in autism
13. + T-cells in autism
14. The effects of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines
15. Energy restriction and zinc deficiency impair the function murine T cells and antigen-presenting cells during gastrointestinal nematode infection
16. Plasma concentration of interleukin-6 and selected plasma proteins in healthy persons of different ages
17. Haloperidol and soluble interleukin-2 receptors
18. Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics
19. Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol
20. Pharmacological activities of chlorpromazine involved in the inhibition of tumor necrosis factor production in vivo in mice
21. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo
22. Interleukin-6 levels in depressed patients before and after treatment with fluoxetine
23. Induction of interleukin-1β and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread areas of rat brain
24. Interactions of the nervous and immune systems in development, normal brain homoeostasis, and disease
25. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes blc-2 and crmA
26. Dexamethasone and pentoxyfylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signalling pathway
27. The regulation tumor necrosis factor-α production in murine mast cells: Pentoxyfylline or dexamethasone inhibits IgE-dependent production of TNF-α by distinct mechanisms
28. Pentoxifylline: Brief review and rationale for its possible use in the treatment of autism
29. On the effects of pentoxifylline upon the EEG activity of early infantile autism: Quantitative pharmacoelectroencephalographic study
30. Deficits in social behavior in autism and their modification by a synthetic adrenocoticotrophin hormone (4-9) analog
31. Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics
32. Pooled human IgG modulates cytokine production in lymphocytes and monocytes